EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Novel Corrector for Variants of SLC6A8: A Therapeutic Opportunity for Creatine Transporter Deficiency

Lara N Gechijian iD, Giovanni Muncipinto, T Justin Rettenmaier, Matthew T Labenski, Victor Rusu, Lea Rosskamp, Leslie Conway, Daniel van Kalken, Liam Gross, Gianna Iantosca, William Crotty iD, Robert Mathis und 11 weitere

ACS Chemical Biology · 2024

DOI: 10.1021/acschembio.4c00571 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Biology, 2024. Verfasst von Lara N Gechijian und 22 weiteren Autor:innen. Beteiligte Einrichtung: Jnana Therapeutics, Boston, Massachusetts 02210, United States. Hauptthemen laut MEDLINE: X-Linked Intellectual Disability, Plasma Membrane Neurotransmitter Transport Proteins. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

X-Linked Intellectual DisabilityPlasma Membrane Neurotransmitter Transport ProteinsAnimalsHumansMiceCreatineSmall Molecule LibrariesBrain Diseases, Metabolic, InbornHEK293 CellsMutationMuscle HypotoniaNerve Tissue ProteinsLanguage Development DisordersMembrane Transport Proteins

Substanzen

Plasma Membrane Neurotransmitter Transport ProteinsSLC6A8 protein, humanCreatineSmall Molecule LibrariesNerve Tissue Proteinscreatine transporterMembrane Transport Proteins

Autor:innen und Institutionen

  • Jnana Therapeutics, Boston, Massachusetts 02210, United States.
  • Third Harmonic Bio, Cambridge, Massachusetts 02139, United States.
  • Apple Tree Partners, New York, New York 10169, United States.
  • Oregon State University, Portland, Oregon 97331, United States.
  • Atavistik Bio, Cambridge, Massachusetts 02140, United States.
  • Neumora Tx, Watertown, Massachusetts 02472, United States.

ORCID-Profile: Lara N Gechijian, William Crotty, Matthew Lyons, Dean G Brown, Lyn H Jones

Zitieren

APA

Gechijian, L. N., Muncipinto, G., Rettenmaier, T. J., Labenski, M. T., Rusu, V., Rosskamp, L., Conway, L., van Kalken, D., Gross, L., Iantosca, G., Crotty, W., Mathis, R., Park, H., Rabin, B., Westgate, C., Lyons, M., Deshusses, C., Brandon, N., Brown, D. G., …, & Barrish, J. C. (2024). Novel Corrector for Variants of SLC6A8: A Therapeutic Opportunity for Creatine Transporter Deficiency. ACS Chemical Biology. https://doi.org/10.1021/acschembio.4c00571

Vancouver

Gechijian LN, Muncipinto G, Rettenmaier TJ, Labenski MT, Rusu V, Rosskamp L, et al. Novel Corrector for Variants of SLC6A8: A Therapeutic Opportunity for Creatine Transporter Deficiency. ACS Chemical Biology. 2024. doi:10.1021/acschembio.4c00571

BibTeX
@article{Gechijian2024,
  author = {Gechijian, Lara N and Muncipinto, Giovanni and Rettenmaier, T Justin and Labenski, Matthew T and Rusu, Victor and Rosskamp, Lea and Conway, Leslie and van Kalken, Daniel and Gross, Liam and Iantosca, Gianna and Crotty, William and Mathis, Robert and Park, Hyejin and Rabin, Benjamin and Westgate, Christina and Lyons, Matthew and Deshusses, Chloe and Brandon, Nicholas and Brown, Dean G and Blanchette, Heather S and Pullen, Nicholas and Jones, Lyn H and Barrish, Joel C},
  title = {Novel Corrector for Variants of SLC6A8: A Therapeutic Opportunity for Creatine Transporter Deficiency},
  journal = {ACS Chemical Biology},
  year = {2024},
  doi = {10.1021/acschembio.4c00571}
}
Kostenlos starten →